emerging-infectious-diseases

Documents about emerging-infectious-diseases

• Activation of the Listeria monocytogenes Virulence Program by a Reducing Environment#491807eScholarship
• Pretreatment chest x-ray severity and its relation to bacterial burden in smear positive pulmonary tuberculosis#634755eScholarship
• Identification of proteins influencing CRISPR-associated transposases for enhanced genome editing#996368eScholarship
• Comparative protein engineering redirects the specificity of Clostridium botulinum proteases#983407eScholarship
• Causes and Consequences of Emerging and Exotic Diseases of Animals: Role of the Veterinarian#239246Iowa State University Digital Repository
• First-Line Treatment for HIV-2#802042ClinicalTrials.gov
• Transmission of Covid-19 During Clubbing Events in Closed Places#857867ClinicalTrials.gov
• Integrin β7 sustains ileal humoral immunity and microbial biogeography during chronic TNF-driven ileitis#780579eScholarship
• Changing Prevalence of Potential Mediators of Aminoquinoline, Antifolate, and Artemisinin Resistance Across Uganda#996345eScholarship
• Activity of the Pore-Forming Virulence Factor Listeriolysin O Is Reversibly Inhibited by Naturally Occurring S-Glutathionylation#491833eScholarship
• Evolution of ocular defects in infant macaques following in utero zika virus infection#996284eScholarship
• Laser‐generated shockwaves enhance antibacterial activity against biofilms in vitro#612065eScholarship
• Multiple lineages of Streptomyces produce antimicrobials within passalid beetle galleries across eastern North America#629281eScholarship
• Expansion of the global RNA virome reveals diverse clades of bacteriophages#784267eScholarship
• Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant#996264eScholarship
• Impact of Delay Between Administration of Inmazeb Administration and Vaccination by Ervebo on Vaccine Immune Response on Healthy Volunteers#152476ClinicalTrials.gov
• Diagnostics and Surveillance of Acute Meningo-encephalitis Among Children in Cambodia With a Focus on Japanese Encephalitis Virus#884522ClinicalTrials.gov
• Severity of the New UK SARS-Cov2 Variant in COVID-19 Infection#899252ClinicalTrials.gov
• Tulane virus protease as a structural surrogate for inhibitor screening of human norovirus proteases#612279eScholarship
• SARS-CoV-2 pseudoparticles preferentially infect ectoderm in human embryonic tissues#620103eScholarship
• Immune profiling links autoimmune hepatitis to human herpesvirus 6 and relaxin receptor antigens#612269eScholarship
• Statistical and machine learning approaches for understanding infectious disease dynamics in response to environmental change: applications to emerging fungal diseases#642205eScholarship
• Henipaviruses at the threshold: preparedness in the era of recurrent spillover#273465Europe PMC
• Efficacy of a Large Language Model Data Extraction System in Evidence Reviews for Emerging Infectious Diseases: A Randomized Crossover Trial.#399790NCBI PubMed Central
• Liver Transplantation in Patients With Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Coinfection#831499ClinicalTrials.gov
• National Multicenter Trial Evaluating Two Treatments in Patients With Primary Human Immunodeficiency Virus (HIV-1) Infection#882557ClinicalTrials.gov
• Salvage Therapy With Amprenavir, Lopinavir and Ritonavir in HIV-infected Patients in Virological Failure.#917567ClinicalTrials.gov
• National Cohort of Patients Co-infected With Hepatitis B and Delta Viruses#979597ClinicalTrials.gov
• The origins of SARS-CoV-2: A critical review#1015681eScholarship
• Interferon lambda 3 genotype predicts hepatitis C virus RNA levels in early acute infection among people who inject drugs: The InC3 Study#684030eScholarship
• Prenatal Zika virus exposure is associated with lateral geniculate nucleus abnormalities in juvenile rhesus macaques#996283eScholarship
• The transcription factor Fli1 restricts the formation of memory precursor NK cells during viral infection#634749eScholarship
• A review of drivers of emerging infectious diseases within the wildlife-human-domestic animal interface in the West Pacific Tropics.#30906NCBI PubMed Central
• Dose Escalation Trial of CD40.HIVRI.Env Vaccine Combined or Not With a DNA-HIV-PT123 HIV-1 Vaccine in Healthy Volunteers#217088ClinicalTrials.gov
• Trial Comparing Two Strategies of Vaccination Against Hepatitis B in HIV-infected Patients Non Responding to Primary Immunization (B-BOOST)#234480ClinicalTrials.gov
• Safety and Immunogenicity of a Sub-unit Protein CD40.RBDv Bivalent COVID-19 Vaccine, Adjuvanted or Not, as a Booster in Volunteers.#314396ClinicalTrials.gov
• Wastewater Resistance Dynamics: Antibiotic–Disinfectant Interaction Patterns, Surveillance, and Emerging Containment Strategies#642731Figshare
• Evaluation of the National Treatment Program of Hepatitis C in Egypt#806154ClinicalTrials.gov
• Efficacy of Tenofovir Disoproxil on Mother-to-child Transmission of HBV in Tokombéré, Cameroon in Pregnant Women#844898ClinicalTrials.gov
• In Vitro Antimicrobial Activities of Organic Acids and Their Derivatives on Several Species of Gram-Negative and Gram-Positive Bacteria#491772eScholarship
• Universal Polymerase Chain Reaction and Antibody Testing Demonstrate Little to No Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in a Rural Community#619922eScholarship
• Differential Inhibitory Receptor Expression on T Cells Delineates Functional Capacities in Chronic Viral Infection#491768eScholarship
• Crystal Structure and Mechanistic Molecular Modeling Studies of Mycobacterium tuberculosis Diterpene Cyclase Rv3377c#619917eScholarship
• A review of drivers of emerging infectious diseases within the wildlife-human-domestic animal interface in the West Pacific Tropics.#121222PubMed
• Evaluation of the Immunogenicity and Safety of Ad26.COV2.S's COVID-19 Vaccine#123540ClinicalTrials.gov
• Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis#844972ClinicalTrials.gov
• Early Identification and Treatment of Early HIV Infection in Côte d'Ivoire#862076ClinicalTrials.gov
• Establishment and characterization of an hACE2/hTMPRSS2 knock-in mouse model to study SARS-CoV-2#996187eScholarship
• Carbon nanotube substrates enhance SARS-CoV-2 spike protein ion yields in matrix-assisted laser desorption–ionization mass spectrometry#1038650eScholarship
• Micro RNA as Prediction and/or Prognostic Markers of IRIS in TB-HIV Co-infected Patients#883738ClinicalTrials.gov